Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
P/B ratio for Definitive Healthcare Corp. (DH)
P/B ratio as of 2023: 1.30
According to Definitive Healthcare Corp.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.30. At the end of 2022 the company had a P/B ratio of 1.17.
P/B ratio history for Definitive Healthcare Corp. from 2019 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 1.30 |
| 2022 | 1.17 |
| 2021 | 3.04 |
| 2020 | 3.51 |
| 2019 | 5.31 |